The authors reported the fine surface editing of MSC-EXOs by the metabolic glycoengineering of adipose-derived stem cells to target activated macrophages in the inflamed joints of rheumatoid arthritis.
[Science Advances]
Sorry, but the selected Zotpress account can't be found.